The global whole genome amplification market is expected to grow at a CAGR of around 8.5% during the forecast period, from 2021 to 2030. The market is driven by factors such as increasing demand for personalized medicine and rising prevalence of chronic diseases. The single cell WGA kit segment accounted for the largest share in the global whole genome amplification market in 2018, followed by complete WGA kit and WGA reamplification kit segments. The single cell WGA kit segment is expected to maintain its dominance throughout the forecast period due to its ability to amplify DNA from a single cell with high accuracy and sensitivity.
The application segments that are driving growth in this market are drug discovery & development, disease diagnosis, agriculture & veterinary, research and forensics. Drug discovery & development accounted for the largest share in this market in 2018 due to increasing demand for personalized medicine which has led pharmaceutical companies towards developing drugs that can be tailored according to an individual’s genetic makeup or genotype profile. Disease diagnosis was another major application segment accounting for over 25% of total revenue generated by this industry in 2018 owing primarily due to increased incidence rates of chronic diseases such as cancer and diabetes globally which have led healthcare providers towards adopting molecular diagnostics techniques such as whole genome sequencing (WGS) or next-generation sequencing (NGS). Agriculture & veterinary was another major application segment accounting for over 10% of total revenue generated by this industry owing primarily due to growing awareness among farmers about precision farming techniques which require accurate identification of plant species through DNA analysis using molecular biology tools like PCR or qPCR kits.
Some Of The Growth Factors Of This Market:
- The need for more sensitive and accurate detection of pathogens in clinical samples.
- The need for more sensitive and accurate detection of pathogens in environmental samples.
- The need to detect low-level pathogens that are difficult to culture.
- The need for rapid, cost-effective, and high throughput methods for pathogen detection.
- Increasing demand from the pharmaceutical industry.
Industry Growth Insights published a new data on “Whole Genome Amplification Market”. The research report is titled “Whole Genome Amplification Market research by Types (Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit, Others), By Applications (Drug Discovery & Development, Disease Diagnosis, Agriculture & Veterinary, Research, Forensics, Others), By Players/Companies Sigma-Aldrich, QIAGEN NV, GE Healthcare, LGC Group”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Whole Genome Amplification Market Research Report
By Type
Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit, Others
By Application
Drug Discovery & Development, Disease Diagnosis, Agriculture & Veterinary, Research, Forensics, Others
By Companies
Sigma-Aldrich, QIAGEN NV, GE Healthcare, LGC Group
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
237
Number of Tables & Figures
166
Customization Available
Yes, the report can be customized as per your need.
Global Whole Genome Amplification Market Report Segments:
The global Whole Genome Amplification market is segmented on the basis of:
Types
Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Drug Discovery & Development, Disease Diagnosis, Agriculture & Veterinary, Research, Forensics, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Sigma-Aldrich
- QIAGEN NV
- GE Healthcare
- LGC Group
Highlights of The Whole Genome Amplification Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Single Cell WGA Kit
- Complete WGA Kit
- WGA Reamplification Kit
- WGA & Chip DNA Kit
- Others
- By Application:
- Drug Discovery & Development
- Disease Diagnosis
- Agriculture & Veterinary
- Research
- Forensics
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Whole Genome Amplification Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Whole genome amplification (WGA) is a technique used to amplify the entire DNA sequence of a sample. This can be done by using specific enzymes to copy large sections of the genome multiple times. This process can result in an increased amount of usable DNA for research or analysis.
Some of the major companies in the whole genome amplification market are Sigma-Aldrich, QIAGEN NV, GE Healthcare, LGC Group.
The whole genome amplification market is expected to register a CAGR of 8.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Whole Genome Amplification Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Whole Genome Amplification Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Whole Genome Amplification Market - Supply Chain
4.5. Global Whole Genome Amplification Market Forecast
4.5.1. Whole Genome Amplification Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Whole Genome Amplification Market Size (000 Units) and Y-o-Y Growth
4.5.3. Whole Genome Amplification Market Absolute $ Opportunity
5. Global Whole Genome Amplification Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Whole Genome Amplification Market Size and Volume Forecast by Type
5.3.1. Single Cell WGA Kit
5.3.2. Complete WGA Kit
5.3.3. WGA Reamplification Kit
5.3.4. WGA & Chip DNA Kit
5.3.5. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Whole Genome Amplification Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Whole Genome Amplification Market Size and Volume Forecast by Application
6.3.1. Drug Discovery & Development
6.3.2. Disease Diagnosis
6.3.3. Agriculture & Veterinary
6.3.4. Research
6.3.5. Forensics
6.3.6. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Whole Genome Amplification Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Whole Genome Amplification Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Whole Genome Amplification Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Whole Genome Amplification Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Whole Genome Amplification Demand Share Forecast, 2019-2026
9. North America Whole Genome Amplification Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Whole Genome Amplification Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Whole Genome Amplification Market Size and Volume Forecast by Application
9.4.1. Drug Discovery & Development
9.4.2. Disease Diagnosis
9.4.3. Agriculture & Veterinary
9.4.4. Research
9.4.5. Forensics
9.4.6. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Whole Genome Amplification Market Size and Volume Forecast by Type
9.7.1. Single Cell WGA Kit
9.7.2. Complete WGA Kit
9.7.3. WGA Reamplification Kit
9.7.4. WGA & Chip DNA Kit
9.7.5. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Whole Genome Amplification Demand Share Forecast, 2019-2026
10. Latin America Whole Genome Amplification Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Whole Genome Amplification Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Whole Genome Amplification Market Size and Volume Forecast by Application
10.4.1. Drug Discovery & Development
10.4.2. Disease Diagnosis
10.4.3. Agriculture & Veterinary
10.4.4. Research
10.4.5. Forensics
10.4.6. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Whole Genome Amplification Market Size and Volume Forecast by Type
10.7.1. Single Cell WGA Kit
10.7.2. Complete WGA Kit
10.7.3. WGA Reamplification Kit
10.7.4. WGA & Chip DNA Kit
10.7.5. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Whole Genome Amplification Demand Share Forecast, 2019-2026
11. Europe Whole Genome Amplification Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Whole Genome Amplification Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Whole Genome Amplification Market Size and Volume Forecast by Application
11.4.1. Drug Discovery & Development
11.4.2. Disease Diagnosis
11.4.3. Agriculture & Veterinary
11.4.4. Research
11.4.5. Forensics
11.4.6. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Whole Genome Amplification Market Size and Volume Forecast by Type
11.7.1. Single Cell WGA Kit
11.7.2. Complete WGA Kit
11.7.3. WGA Reamplification Kit
11.7.4. WGA & Chip DNA Kit
11.7.5. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Whole Genome Amplification Demand Share, 2019-2026
12. Asia Pacific Whole Genome Amplification Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Whole Genome Amplification Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Whole Genome Amplification Market Size and Volume Forecast by Application
12.4.1. Drug Discovery & Development
12.4.2. Disease Diagnosis
12.4.3. Agriculture & Veterinary
12.4.4. Research
12.4.5. Forensics
12.4.6. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Whole Genome Amplification Market Size and Volume Forecast by Type
12.7.1. Single Cell WGA Kit
12.7.2. Complete WGA Kit
12.7.3. WGA Reamplification Kit
12.7.4. WGA & Chip DNA Kit
12.7.5. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Whole Genome Amplification Demand Share, 2019-2026
13. Middle East & Africa Whole Genome Amplification Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Whole Genome Amplification Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Whole Genome Amplification Market Size and Volume Forecast by Application
13.4.1. Drug Discovery & Development
13.4.2. Disease Diagnosis
13.4.3. Agriculture & Veterinary
13.4.4. Research
13.4.5. Forensics
13.4.6. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Whole Genome Amplification Market Size and Volume Forecast by Type
13.7.1. Single Cell WGA Kit
13.7.2. Complete WGA Kit
13.7.3. WGA Reamplification Kit
13.7.4. WGA & Chip DNA Kit
13.7.5. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Whole Genome Amplification Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Whole Genome Amplification Market: Market Share Analysis
14.2. Whole Genome Amplification Distributors and Customers
14.3. Whole Genome Amplification Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Sigma-Aldrich
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. QIAGEN NV
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. GE Healthcare
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. LGC Group
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. COMPANY5
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. COMPANY6
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
